The key finding
Researchers reviewed evidence for sulforaphane—a natural compound found in broccoli, Brussels sprouts, and other cruciferous vegetables—as a potential supportive agent for various skin conditions and UV-related skin damage. The compound works by activating cellular defense pathways, particularly the Keap1/Nrf2 system, which helps reduce oxidative stress and inflammation in skin cells. While preclinical studies show promise across multiple skin disorders including atopic dermatitis, psoriasis, acne, and rosacea, the strongest current human evidence relates specifically to UV-associated skin outcomes and photoprotection. The 2026 review emphasizes that sulforaphane remains an early-stage translational candidate, with robust human efficacy data still lacking for most chronic inflammatory skin conditions.
What the study looked like
This was a comprehensive review of existing research on sulforaphane’s effects on skin health, published in the journal Nutrients in 2026. The authors examined preclinical studies (cell culture and animal models), limited human trials, and mechanistic data exploring how sulforaphane influences various skin conditions. Rather than conducting new experiments, the researchers synthesized findings across diverse cutaneous disorders—including inflammatory conditions like atopic dermatitis, psoriasis, acne vulgaris, and rosacea, as well as UV-induced skin injury and photoaging. They analyzed how sulforaphane interacts with key biological pathways involved in skin health: immune regulation, inflammation control, oxidative stress response, skin barrier function, and microbiome balance. The review explicitly acknowledged that these conditions are biologically heterogeneous and should not be treated as a single mechanistic category.
Why researchers think this happened
Sulforaphane’s potential skin benefits appear to stem from its ability to activate the Keap1/Nrf2 pathway, a master regulator of cellular antioxidant defenses. When this pathway is activated, cells increase production of protective enzymes that neutralize damaging reactive oxygen species and reduce oxidative stress—a common factor in many skin conditions. In some contexts, sulforaphane also modulates NF-κB-related signaling, which plays a central role in inflammatory responses. By influencing these pathways, sulforaphane may help regulate immune responses that contribute to conditions like atopic dermatitis and psoriasis, strengthen the skin’s protective barrier function, and potentially influence the composition of skin microbiome communities. The compound’s cytoprotective properties may explain why the strongest human evidence currently relates to UV protection: ultraviolet radiation generates substantial oxidative stress in skin, and sulforaphane’s antioxidant mechanisms appear particularly relevant in this setting. Preclinical studies have documented reductions in erythema (redness), edema (swelling), and other markers of cutaneous damage in selected experimental conditions.
How to read this carefully
Several important limitations constrain how we should interpret this evidence. First, much of the data comes from cell culture experiments and animal studies, which frequently fail to predict human responses accurately—skin physiology differs substantially between species. Second, the review explicitly states that robust human efficacy data remain lacking for chronic inflammatory dermatoses including psoriasis, atopic dermatitis, acne, and rosacea. Third, significant translational challenges exist: formulation and delivery methods vary widely, no standardized dosing has been established, and sulforaphane’s bioavailability when applied topically or consumed orally remains uncertain. Fourth, the reviewed skin conditions are biologically heterogeneous—mechanisms driving psoriasis differ from those underlying acne—so findings from one condition may not generalize. Finally, this is a review synthesizing existing research rather than presenting new clinical trial data, and the authors characterize sulforaphane as an “early-stage translational candidate” rather than an established therapeutic approach.
What this means for everyday life
For now, sulforaphane research primarily highlights the broader principle that compounds in vegetables may influence skin health through antioxidant and anti-inflammatory pathways. Given that the strongest current evidence relates to UV protection, and that cruciferous vegetables like broccoli, Brussels sprouts, and cauliflower are already recommended as part of a balanced diet for numerous health reasons, incorporating these foods represents a reasonable nutritional choice. However, readers should not interpret this research as evidence that eating broccoli will treat inflammatory skin conditions—the human data simply aren’t there yet. The review’s emphasis on translational constraints serves as a reminder that “promising in the lab” rarely translates directly to clinical effectiveness. If you’re managing a chronic skin condition, evidence-based treatments prescribed by dermatologists remain the appropriate first-line approach. The sulforaphane story illustrates how scientific understanding develops gradually, moving from mechanism to animal studies to small human trials before—if warranted—reaching clinical application.